药物耐药青少年肌性:文献综述
1Epilepsy Unit, Reference Center for Rare Epilepsies, Neurology Department, Clinical Investigation Center 1414, Rennes University Hospital, Rennes, France; Signal and Image Processing Laboratory (LTSI), INSERM, Rennes University, Rennes, France.
Revue neurologique
|March 9, 2024
概括
青少年肌性 (JME) 影响了许多人,但药物耐药性发生在三分之一的患者. 研究确定风险因素,探索神经生理标志物和GABAergic抑制,以获得更好的JME治疗策略.
科学领域:
- 神经学 神经学
- 发病学 (Epileptology) 是一个专业的学科.
- 临床神经科学 临床神经科学
背景情况:
- 青少年肌性 (JME) 是最常见的特异性普遍性.
- 最近对JME定义的修订强调了不断变化的诊断标准.
- 药物耐药性 (DR) 影响高达33%的JME患者,需要与伪耐药性区分开来.
研究的目的:
- 审查目前的定义和JME的诊断方面.
- 确定与耐药性JME (DR-JME) 相关的风险因素.
- 探索DR-JME背后的神经生理和遗传机制以及潜在的治疗途径.
主要方法:
- 审查现有文献,包括关于JME的研究和元分析.
- 对DR-JME的风险因素的分析.
- 检查神经生理标记 (皮层刺激,网络连接) 和神经传递研究 (GABAergic抑制).
主要成果:
- 缺席性发作,发病时年轻,性发作是DR-JME的关键风险因素.
- 光敏度可以预测女性患者的良好治疗反应.
- 损坏的GABAergic抑制是DR-JME病理生理学的首要嫌疑人,神经生理学标记与耐药性和相关疾病相关.
结论:
- 了解DR-JME需要进一步调查其复杂的神经生理学基础.
- 开发新的治疗方法至关重要,考虑到对传统药物的限制,如酸.
- 对JME机制和治疗方法的持续研究对于改善患者的治疗结果至关重要.
相关概念视频
01:24Arteries of the Lower Limbs
189
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
189
01:13Seizures: Classification
347
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
347
01:20Antiepileptic Drugs: Potassium Channel Activators
183
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
183
01:14Antiepileptic Drugs: Glutamate Antagonists
345
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
345
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
296
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
296
01:20Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K